The effects of TNF-alpha inhibitor therapy on arterial stiffness and endothelial dysfunction in rheumatoid arthritis: A meta-analysis

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 3, 2013, Pages

  Mathieu, Sylvain ^a   Couderc, Marion ^a   Pereira, Bruno ^b   Soubrier, Martin ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; AUGMENTATION INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DAS28; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATION; HEART LEFT VENTRICLE MASS; HUMAN; LETTER; PRIORITY JOURNAL; PULSE WAVE; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTERIOSCLEROSIS; ARTHRITIS, RHEUMATOID; HUMANS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR STIFFNESS;

EID: 84889606654     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.05.005     Document Type: Letter

References (4)

1. Dalai R., Perry M., Twycross-Lewis R., Morrissey D., Atzeni F., Grrenwald S. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review. Semin Arthritis Rheum 2012, 42:1-8.
2. Barnabe C.C.M., Martin B.J., Ghali W.A. Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 2011, 63:522-529.
3. Mäki-Petäjä K.M., Elkhawad M., Cheriyan J., Joshi F.R., Ostör A.J., Hall F.C., et al. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 2012, 126:2473-2480.
4. Daïen C.I., Fesler P., du Cailar G., Daïen V., Mura T., Dupuy A.M., et al. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Ann Rheum Dis 2013, 72:881-887.